Warning letter · FDA Warning Letters

RAAS Nutritionals, LLC/Rare Antibody Antigen Supply, Inc.: FDA Warning Letter 616560 (Sep 30, 2021)

Agency action: Sep 30, 2021Record ID: fda_warning_-ec98f8677db78e05
View official source ↗

What happened

Original notice title

RAAS Nutritionals, LLC/Rare Antibody Antigen Supply, Inc. MARCS-CMS 616560, September 30, 2021

From the archived source record

Department of Health and Human Services; and the former Commissioner of Food and Drugs Stephen Hahn, M.D., regarding the use of its “non-pharmaceutical products” (b)(4) . Without this information, we are unable to determine whether RAAS’s stated intent to comply with IND regulations is adequate to prevent similar violations in the future. Within 15 business days of your receipt of this letter, you should notify this office in writing of the actions you have taken to prevent similar violations in the future. Failure to adequately address this matter may lead to regulatory action. If you have any questions, please call Miah Jung, Pharm.D., M.S., at 240-402-3728. Your written response and any pertinent documentation should be addressed to: Miah Jung, Pharm.D., M.S.

What the official notice says to do

Check the original notice for the instructions that apply to the named product, company, and affected lots.

Read the official notice →

Status and source details

Status recorded in the archive
No closeout listed in FDA table
Source checked
Jul 16, 2026
Record revision
9ae9cce17d87

This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.

Sources, dates, and coverage →

What is affected

Product
presented and discussed with you and your staff the Form FDA 483; Inspectional Observations
Company
RAAS Nutritionals, LLC/Rare Antibody Antigen Supply, Inc.
Lot / identifier
The source does not specify this field.
Market / distribution
The source does not specify this field.